Table 1.
Item | Groups | --P-- | ||||
---|---|---|---|---|---|---|
Control | Sildenafil | Mucuna pruriens | Tribulus terrestris | Ashwagandha | ||
Final body weight, g | 324.00 ± 24.84 | 316.57 ± 17.99 | 312.00 ± 29.73 | 307.71 ± 52.45 | 331.80 ± 28.31 | >0.05 |
Testis, g | 1.39 ± 0.07 | 1.35 ± 0.11 | 1.35 ± 0.09 | 1.36 ± 0.14 | 1.33 ± 0.08 | >0.05 |
Whole epididymis, g | 0.58 ± 0.05 | 0.61 ± 0.04 | 0.56 ± 0.05 | 0.58 ± 0.07 | 0.59 ± 0.04 | >0.05 |
Right cauda epididymis, g | 0.25 ± 0.03 | 0.24 ± 0.03 | 0.24 ± 0.03 | 0.23 ± 0.05 | 0.23 ± 0.02 | >0.05 |
Vas deferens, g | 0.12 ± 0.01 | 0.13 ± 0.01 | 0.12 ± 0.01 | 0.13 ± 0.01 | 0.13 ± 0.01 | >0.05 |
Seminal vesicles, g | 1.16 ± 0.30 | 1.10 ± 0.25 | 1.09 ± 0.18 | 1.17 ± 0.24 | 1.39 ± 0.31 | >0.05 |
Ventral prostate, g | 0.43 ± 0.07 | 0.49 ± 0.07 | 0.41 ± 0.07 | 0.50 ± 0.17 | 0.48 ± 0.18 | >0.05 |
Testis*, % | 0.43 ± 0.04 | 0.43 ± 0.04 | 0.43 ± 0.05 | 0.45 ± 0.05 | 0.40 ± 0.03 | >0.05 |
Whole epididymis*, % | 0.18 ± 0.02 | 0.19 ± 0.02 | 0.18 ± 0.02 | 0.19 ± 0.02 | 0.18 ± 0.01 | >0.05 |
Right cauda epididymis*, % | 0.08 ± 0.01 | 0.08 ± 0.01 | 0.08 ± 0.01 | 0.08 ± 0.01 | 0.07 ± 0.004 | >0.05 |
Vas deferens*, % | 0.04 ± 0.005 | 0.04 ± 0.008 | 0.04 ± 0.003 | 0.04 ± 0.007 | 0.04 ± 0.004 | >0.05 |
Seminal vesicles*, % | 0.36 ± 0.09 | 0.35 ± 0.09 | 0.35 ± 0.05 | 0.38 ± 0.06 | 0.42 ± 0.9 | >0.05 |
Ventral prostate*, % | 0.13 ± 0.02 | 0.15 ± 0.02 | 0.13 ± 0.02 | 0.16 ± 0.04 | 0.14 ± 0.05 | >0.05 |
*Relative reproductive organ weights [organ weight (g) / final body weight (g) X 100]
Control, no treatment; Sildenafil, rats treated with Sildenafil (5 mg/kg/d); Mucuna, rats treated with Mucuna pruriens (300 mg/kg bw); Tribulus; rats treated with Tribulus terrestris (300 mg/kg bw); Ashwagandha; rats treated with Ashwagandha (300 mg/kg bw). Data are LS means ± SE (n = 7). Different superscripts in the same row (a–c) indicate group mean differences (p < 0.05)